Key Milestones in Cytogenetics and the Human Genome
Page 1: HISTORY of CYTOGENETICS and HUMAN GENOME
- Cytogenetics studies chromosomes and their role in heredity; history features landmark discoveries and technique advancements leading to the genome era.
Page 2: Cytogenetics Overview
- Definition: Cytogenetics is the study of chromosomes and their role in heredity.
- Evolution: From early observations to a crucial tool for understanding genetic diseases and cellular processes.
Page 3: Early Observations (1842-1882)
- Karl Nägeli observed chromosomes in pollen cells in 1842.
- Walther Flemming introduced aniline staining to visualize chromosomes during cell division in 1870.
Page 4: Mendel's Laws and Chromosomes (1902)
- Theodor Boveri and Walter Sutton linked chromosome behavior to Mendel's laws of inheritance; established the chromosome theory of inheritance in 1902.
Page 5: Chromosome Theory of Inheritance (1912)
- Thomas Hunt Morgan and Calvin Bridges advanced the field by discovering linkage and solidifying the chromosomal theory of inheritance in 1912.
- In 1921, the human chromosome number was initially set at 48; later corrected to 46 in 1956 by Joe Hin Tjio and Albert Leva.
Page 7: First Diagnosis of Chromosomal Aberration (1959)
- Jérôme Lejeune successfully diagnosed trisomy 21 (Down syndrome) in three cases, marking the first successful diagnosis of a human chromosomal aberration.
Page 8: THE HUMAN GENOME
- Until the early 1970s, DNA was the most difficult cellular molecule to analyze; now it is the easiest to analyze — regions can be isolated, copied repeatedly, and sequenced.
- At the peak of the Human Genome Project, sequencing factories generated DNA sequences at about 1000 nucleotides per second, 24/7.
- Technical breakthroughs that allowed the Human Genome Project to progress.
Page 9: The Genome
- The genome is the entire genetic makeup of the human cell nucleus.
- Genes carry information for making all body proteins; the genome also encodes rRNA and tRNA involved in protein synthesis.
Page 10: Goals
- Identify all approximately 3×104 genes in human DNA.
- Determine the sequences of the 3×109 chemical base pairs of human DNA.
- Store this information in databases.
- Improve tools for data analysis.
Page 11: Milestones
- 1990: Project initiated as a joint effort of the U.S. Department of Energy and the National Institutes of Health.
- June2000: Completion of a working draft of the entire genome (covers >90% of the genome to a depth of 3−4× redundant sequence).
- February2001: Analyses of the working draft are published.
- April2003: HGP sequencing is completed and the project is declared complete.
Page 12: Genome Files
- Human (Homo sapiens): genome size 3×109 bases; estimated genes 3×104.
- Laboratory mouse (M. musculus): 2.6×109 bases; 3×104 genes.
- Mustard weed (A. thaliana): 1×108 bases; 2.5×104 genes.
- Roundworm (C. elegans): 9.7×107 bases; 1.9×104 genes.
- Fruit fly (D. melanogaster): 1.37×108 bases; 1.3×104 genes.
- Yeast (S. cerevisiae): 1.21×107 bases; 6×103 genes.
- Bacterium (E. coli): 4.6×106 bases; 3.2×103 genes.
- Human immunodeficiency virus (HIV): genome size 9.7×103 bases; 9 genes.
Page 13: Significance of DNA Identification (Forensics)
- Identify potential suspects whose DNA may match evidence left at crime scenes.
- Exonerate persons wrongly accused of crimes.
- Identify crime and catastrophe victims; establish paternity and other family relationships.
- Identify endangered and protected species to aid wildlife officials (could be used for prosecuting poachers).
- Detect bacteria and other organisms that may pollute air, water, soil, and food.
- Match organ donors with recipients in transplant programs.
- Determine pedigree for seed or livestock breeds.
- Authenticate consumables such as caviar and wine.
Page 14: Ethical, Legal, and Social Issues (ELSI)
- Privacy and confidentiality of genetic information.
- Fairness in the use of genetic information by insurers, employers, courts, schools, adoption agencies, and the military, among others.
- Psychological impact, stigmatization, and discrimination due to an individual’s genetic differences.
- Reproductive issues including adequate and informed consent and use of genetic information in reproductive decision making.
- Clinical issues including education of doctors and other health-service providers, people identified with genetic conditions, and the general public about capabilities, limitations, and social risks; and implementation of standards and quality-control measures.